PHARNEXT: Pharnext in discussions with investment research firm Edison to update valuation of assets
PARIS, France, January 5th, 2023, 08:30 am CET - Pharnext SA (FR001400BV89 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative
Source: finanznachrichten.de